Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 30184
Incidence of Acinetobacter in Fresh Carrot (Daucus carota subsp. sativus)

Authors: M. Dahiru, O. I. Enabulele


The research aims to investigate the occurrence of multidrug-resistant Acinetobacter, in carrot and estimate the role of carrot in its transmission in a rapidly growing urban population. Thus, 50 carrot samples were collected from Jakara wastewater irrigation farms and are analyzed on MacConkey agar and screened by Microbact 24E (Oxoid) and susceptibility of isolates is tested against 10 commonly used antibiotics. Acinetobacter baumannii and A. lwoffii were isolated in 22.00% and 16% of samples respectively. Resistance to ceporex and penicillin of 36.36% and 27.27% in A. baumannii, and sensitivity to ofloxacin, pefloxacin, gentimycin and co-trimoxazole were observed. However, for A. lwoffii apart from 37.50% resistance to ceporex, it was also resistant to all other drugs tested. There were similarities in the resistances shown by A. baumannii and A. lwoffii to fluoroquinolones and β- lactame drug families in addition to between sulfonamide and animoglycoside demonstrated by A. lwoffii. Significant correlation in similarities were observed at P < 0.05 to CPX to NA (46.2%), and SXT to AU (52.6%) A. baumannii and A. lwoffii respectively and high multi drug resistance (MDR) of 27.27% and 62.50% by A. baumannii and A. lwoffii respectively. The occurrence of multidrug-resistance pathogen in carrot is a serious challenge to public health care, especially in a rapidly growing urban population where subsistence agriculture contributes greatly to urban livelihood and source of vegetables.

Keywords: Urban agriculture, Public health, Fluoroquinolone, Sulfonamide, Multidrug-resistance.

Digital Object Identifier (DOI):

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1190


[1] Grace, D., Olowoye, J., Dipeolu, M., Odebode, S., and Randolph, T. “The influence of gender and group membership on food safety: the case of meat sellers in Bodija market, Ibadan, Nigeria. Tropical Animal Health and Production” 44 Suppl 1, S53-9. 11250-012-0207-0, 2012.
[2] Berger, N. C., Samir, V. S., Robert, K. S., Griffin, P. M., David, P., Paul, H. and Gad, F. “Fresh fruit and vegetables as vehicles for the transmission of human pathogens” Environ. Microbiol. 12(9), 2385– 2397, 2010.
[3] FAO/WHO “Risk profile for enteroheamorrhagic Escherichia coli including the Identification of the Commodities of Concern, including Sprouts, Ground Beef and Pork” CX/FH 03/5/Add.4 Sept. 2002. Codex alimentarious commission, 2003.
[4] Makita, K., Desissa, F., Teklu, A., Zewde, G., and Grace, D. “Risk assessment of staphylococcal poisoning due to consumption of informally-marketed milk and home-made yoghurt in Debre Zeit, Ethiopia”. International Journal of Food Microbiology, 153(1-2), 135- 41, 2012.
[5] Amoah, P., Drechsel, P., Henseler, M. and Abaidoo, R. C. “Irrigated urban vegetable production in Ghana: microbiological contamination in farms and markets and associated consumer risk groups” Journal of Water Health. 5, 455-66, 2007.
[6] World Health Organization “Guidelines for the safe use of wastewater, excreta and greywater” 2006. Retrieved from,
[7] Ndiaye, M. L., Dieng, Y., Niang, S., Pfeifer, H. R., Tonolla, M., and Peduzzi, R. “Effect of irrigation water on the incidence of Salmonella spp. on lettuces produced by urban agriculture and sold on the markets in Dakar, Senegal”. African Journal of Microbiology Research, 5(19), 2885-2890, 2011.
[8] Schreckenberger P. C., Daneshvar M. I., Weyant R. S., and Hollis D. G. “Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative gramnegative rods” In: Murray P. R., Baron E. J., .Jorgensen J. H., Landry M. L., Pfaller M. A., eds. Manual of clinical microbiology. 9th ed. Washington, DC: ASM Press, 2007:770- 802.
[9] Getchell-White S. I., Donowitz L. G., and Groschel D. H. “The inanimate environment of an intensive care unit as a potential source of nosocomial baceria: evidence for long survival of Acinetobacter calcoaceticus” Infect Control Hosp Epidemiol, Vol. 10:402-7, 1989.
[10] Lolans K., Rice T. W., Munoz-Price L. S., and Quinn J. P. “Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40” Antimicrob Agents Chemother, 50:2941-5, 2006.
[11] Talbot G. H., Bradley J., Edwards J. E. Jr, Gilbert D., Scheld M., and Bartlett J. G. “Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America” Clin Infect Dis. 42:657-68, 2006.
[12] Silvia M. L. and Weinstein, R.A. “Acinetobacter Infection” N Engl J Med; 358:1271-81, 2008.
[13] Oncul O, Keskin O, Acar HV, et al. “Hospital-acquired infections following the 1999 Marmara earthquake” J Hosp Infect, 51:47-51, 2002.
[14] Fournier, P. E. and Richet, H. “The epidemiology and control of Acinetobacter baumannii in health care facilities” Clin. Infect. Dis. 42:692-699, 2006.
[15] Dima S., Kritsotakis E. I., Roumbelaki M., et al. “Device-associated nosocomial infection rates in intensive care units in Greece” Infect Control Hosp Epidemiol, 28: 602-5, 2007.
[16] Imperi, F., Antunes, L. C., Blom, J., Villa, L., Iacono, M., Visca, P., and Carattoli, A. “The genomics of Acinetobacter baumannii: insights into genome plasticity, antimicrobial resistance and pathogenicity” IUBMB Life. Dec; 63(12), 1068-74, 2011.
[17] Cheesbrough, M. (2005). District Laboratory practice for tropical countries, Part 2, Cambridge University Press, UK, 426 pp.
[18] Clinical and Laboratory Standards Institute (CLSI) (2007). Performance Standards for Antimicrobial Susceptibility Test Approved Standard (Document M100-S17). 27 (1). 187 pp.
[19] Stine, S. W., Song, I., Choi, C. Y., and Gerba, C. P. “Application of microbial risk assessment to the development of standards for enteric pathogens in water used to irrigate fresh produce” Journal of Food Protection, 68, 913-8, 2005.
[20] Poirel L., and Nordmann P. “Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology” Clin Microbiol Infect; 12:826-36, 2006.
[21] Peleg A. Y., Adams J, and Paterson D. L. “Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii” Antimicrob Agents Chemother; 51: 2065-9, 2007.
[22] Jacoby GA, and Munoz-Price LS. “The new beta-lactamases” N Engl J Med; 352:380-91, 2005.
[23] Qi C, Malczynski M, Parker M, and Scheetz MH. “Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007” Clin Microbiol; 46 : 1106- 9, 2008.
[24] Acar, J. F. and Goldstein, F. W. “Trends in bacterial resistance to fluoroquinolones” Clin Infect Dis. 1997; 24 (suppl 1): S67–73, 1997.
[25] Vila, J., Ruiz, J., Goni, P., Marcos, A., and Jimenez De Anta, T. “Mutation in the gyrA Gene of Quinolone-Resistant Clinical Isolates of Acinetobacter baumannii” Antimicrob Agents Chemother 39 (5): 1201– 1203, 1995.
[26] Chopra S., Torres-Ortiz M., Hokama L. et al. “Repurposing FDAapproved drugs to combat drug-resistant Acinetobacter baumannii” J Antimicrob Chemother; 65: 2598–601, 2010.
[27] World Health Organization. “Antimicrobial resistance: global report on surveillance” 2014. WHO Press, World Health Organization, 20 Avenue Appia, ISBN 978 92 4 156474 8, 3 – 5 or